600750 Stock Overview
Engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Jiang Zhong Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥21.79 |
| 52 Week High | CN¥28.58 |
| 52 Week Low | CN¥18.17 |
| Beta | 0.33 |
| 1 Month Change | 1.68% |
| 3 Month Change | 11.80% |
| 1 Year Change | 6.03% |
| 3 Year Change | 57.33% |
| 5 Year Change | 114.33% |
| Change since IPO | 2,625.37% |
Recent News & Updates
Recent updates
Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750) Analysts Just Slashed This Year's Revenue Estimates By 11%
Sep 12
Lacklustre Performance Is Driving Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E
Jul 20A Look At The Fair Value Of Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750)
May 22Why Investors Shouldn't Be Surprised By Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E
Apr 15Shareholder Returns
| 600750 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 3.7% | -4.3% | -3.5% |
| 1Y | 6.0% | -3.4% | 10.9% |
Return vs Industry: 600750 exceeded the CN Pharmaceuticals industry which returned -3.4% over the past year.
Return vs Market: 600750 underperformed the CN Market which returned 10.9% over the past year.
Price Volatility
| 600750 volatility | |
|---|---|
| 600750 Average Weekly Movement | 4.8% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600750 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600750's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 4,013 | Wenbin Xiao | www.jzjt.com |
Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China. The company offers OTC products for spleen and stomach, intestinal tract, anorectal, throat cough and asthma, supplements and minerals, and chronic diseases. It also offers health products for high-end nourishment, rehabilitation nutrition, gastrointestinal health, liver and gallbladder health, dietary nutrition, basic vitamins, personal care essential oils, and other businesses; and prescription products.
Jiang Zhong Pharmaceutical Co.,Ltd Fundamentals Summary
| 600750 fundamental statistics | |
|---|---|
| Market cap | CN¥13.42b |
| Earnings (TTM) | CN¥750.31m |
| Revenue (TTM) | CN¥4.13b |
18.1x
P/E Ratio3.3x
P/S RatioIs 600750 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600750 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.13b |
| Cost of Revenue | CN¥1.41b |
| Gross Profit | CN¥2.71b |
| Other Expenses | CN¥1.96b |
| Earnings | CN¥750.31m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.20 |
| Gross Margin | 65.81% |
| Net Profit Margin | 18.19% |
| Debt/Equity Ratio | 0% |
How did 600750 perform over the long term?
See historical performance and comparisonDividends
5.5%
Current Dividend Yield101%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 16:41 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiang Zhong Pharmaceutical Co.,Ltd is covered by 15 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jun Wang | BOCI Research Ltd. |
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Shanshan Li | China Merchants Securities Co. Ltd. |